| PERIOD ENDING | 27-Sep-09 | 28-Jun-09 | 29-Mar-09 | 28-Dec-08 | | Total Revenue | 88,811 | 79,403 | 84,513 | 104,562 | | Cost of Revenue | 63,980 | 58,413 | 67,747 | 81,237 | | | Gross Profit | 24,831 | 20,990 | 16,766 | 23,325 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 22,066 | 19,937 | 24,069 | 29,107 | | Non Recurring |
-
|
-
|
-
| 10,730 | | Others | 3,274 | 3,456 | 3,276 | 3,700 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (509) | (2,403) | (10,579) | (20,212) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (509) | (2,403) | (10,579) | (20,212) | | Interest Expense | 703 | 581 | 545 | 571 | | Income Before Tax | (1,212) | (2,984) | (11,124) | (20,783) | | Income Tax Expense |
-
|
-
|
-
| 11,593 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,212) | (2,984) | (11,124) | (32,376) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,212) | (2,984) | (11,124) | (32,376) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,212) | ($2,984) | ($11,124) | ($32,376) |
|
0.02% Nasdaq 0.00%
Income Statement
